Renal Insufficiency  >>  Monofer (iron isomaltoside 1000)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Monofer (iron isomaltoside 1000) / Pharmacosmos
NCT00536666 / 2007-000765-37: A Study of Iron Oligosaccharide in Chronic Kidney Disease Patients

Completed
3
182
Europe
Iron oligosaccharide, MonoFer
Pharmacosmos A/S
Chronic Kidney Disease, Anemia, Iron-Deficiency
08/08
08/08
NCT01222884 / 2010-023471-26: A Randomized, Comparative, Open-label Study of IV Monofer® Administered as Maintenance Therapy by Single or Repeated Bolus Injections in Comparison With IV Iron Sucrose in Subjects With CKD-5D

Completed
3
351
RoW
Monofer, Iron sucrose
Pharmacosmos A/S
Chronic Kidney Disease Stage 5 (Dialysis Dependent)
10/13
12/13
NCT01102413 / 2009-016728-29: Iron Isomaltoside 1000 (Monofer®) in Non-Dialysis Dependent Chronic Kidney Disease and With Renal-Related Anaemia

Completed
3
351
Europe
Monofer, Iron Sulphate
Pharmacosmos A/S
Iron Deficiency Anemia, Chronic Kidney Disease
06/14
06/14

Download Options